Clinical trial
Trial on Refinement of Early Stage Lung Cancer Adjuvant Therapy
NCT00349089 · Thoraxklinik-Heidelberg gGmbH, Other · Completed
Key facts
| NCT number | NCT00349089 |
|---|---|
| Title | Trial on Refinement of Early Stage Lung Cancer Adjuvant Therapy |
| Official title | Adjuvant Chemotherapy With Pemetrexed and Cisplatin vs. Vinorelbine and Cisplatin in NSCLC IB, IIA, IIB, T3N1: a Randomized Phase II Study |
| Lead sponsor | Thoraxklinik-Heidelberg gGmbH, Other |
| Status | Completed |
| Phase | Phase 2 |
| Study type | Interventional |
| Conditions | Non Small Cell Lung Cancer |
| Intervention type | Drug |
| Interventions | Pemetrexed, Cisplatin, Vinorelbine |
| Enrollment | 132 |
| Start date | Sep 26, 2006 |
| Primary completion | Apr 14, 2014 |
| Completion | Apr 14, 2014 |
| First posted | Jul 6, 2006 |
| Last update posted | Sep 19, 2019 |
| Countries | Belgium, Germany, Luxembourg |
At a glance
- 10–99 Study sites
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: